Commentary
Don’t jump to rash conclusions
Downloads and Tools
Volume 11, Issue 7 April 1, 2011
Pages 639 - 641
http://dx.doi.org/10.4161/cbt.11.7.14920
Authors: Gwyn Bebb, William Boland and Barbara Melosky
View affiliations Hide affiliations
- Gwyn Bebb
-
Corresponding author: Gwyn.Bebb@albertahealthservices.ca
Tom Baker Cancer Centre and University of Calgary, Calgary, Alberta, Canada
- William Boland
-
Tom Baker Cancer Centre and University of Calgary, Calgary, Alberta, Canada
- Barbara Melosky
-
British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada
Abstract:
Commentary to:
Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile
Greta Garrido, Ilia A. Tikhomirov, Ailem Rabasa, Eric Yang, Elías Gracia, Normando Iznaga, Luis E. Fernández, Tania Crombet, Robert Kerbel and Rolando Pérez
Received: January 20, 2010; Accepted: January 24, 2010
Preview: